Fig. 2

Kaplan-Meier curve of the association between the occurrence of first hepatotoxicity and BMI. Kaplan-Meier curve in gefitinib-treated patients (A) and in erlotinib-treated patients (B). A log-rank test was used for statistical analysis
Kaplan-Meier curve of the association between the occurrence of first hepatotoxicity and BMI. Kaplan-Meier curve in gefitinib-treated patients (A) and in erlotinib-treated patients (B). A log-rank test was used for statistical analysis